The vaccines, along with other preventative treatments, could change cold season as we know it - Keren Landman
image by: Unbiased Science Podcast
After a decades-long search, vaccines for RSV are finally here. Scientists have been working on the shots since soon after the virus was discovered in 1956. But some disastrous clinical trials in the 1960s and dozens of other failed attempts stymied progress for many years. Now not just one but two RSV vaccines for older adults have been approved by the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention. As of this writing, a vaccine given to pregnant people, designed to protect infants after birth, was on track to be approved by the end of the summer. The breakthrough leading to these developments happened once researchers solved a 50-year-old mystery about…
Decades of failed attempts have given way to several successful vaccines and treatments for the respiratory disease RSV.
ABRYSVO is a vaccine indicated for: the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in people 60 years of age and older pregnant individuals at 32 through 36 weeks gestational age for the prevention of LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age
AREXVY is the first FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people aged 60 years and older.
Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in: Newborns and babies under 1 year of age born during or entering their first RSV season. Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.
Even the best-laid plans could be cut short by RSV. While you may not have heard of it yet, RSV is not a new virus and may be more of a health concern than you think—even if you’re healthy. If you’re aged 60 or over, you can get RSV. But don’t worry, by coming here you’ve taken a savvy first step toward learning about RSV so you can be informed. Let’s dive in..
Vaccines are available to protect older adults from severe RSV. Monoclonal antibody products are available to protect infants and young children from severe RSV.
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.